![Caroline Baumal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caroline Baumal
Technik-/Wissenschafts-/F&E-Leiter bei
APELLIS PHARMACEUTICALS, INC.
Profil
Caroline Baumal currently works at Apellis Pharmaceuticals, Inc., as Chief Medical Officer from 2023 and New England Eye Center, as Professor.
Dr. Baumal received her doctorate degree from the University of Toronto.
Aktive Positionen von Caroline Baumal
| Unternehmen | Position | Beginn |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 03.01.2023 |
New England Eye Center
 New England Eye Center Medical/Nursing ServicesHealth Services Provides ophthalmology care services | Corporate Officer/Principal | 01.01.1998 |
Ausbildung von Caroline Baumal
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New England Eye Center
New England Eye Center Medical/Nursing ServicesHealth Services Provides ophthalmology care services | Health Services |
